These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19630714)

  • 1. Use of caffeine and nicotine in people with schizophrenia.
    Williams JM; Gandhi KK
    Curr Drug Abuse Rev; 2008 Jun; 1(2):155-61. PubMed ID: 19630714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.
    Dalack GW; Healy DJ; Meador-Woodruff JH
    Am J Psychiatry; 1998 Nov; 155(11):1490-501. PubMed ID: 9812108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of smoking cues on caffeine urges in heavy smokers and caffeine consumers with and without schizophrenia.
    Adolfo AB; AhnAllen CG; Tidey JW
    Schizophr Res; 2009 Feb; 107(2-3):192-7. PubMed ID: 19006656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine consumption in a long-term psychiatric hospital: Tobacco smoking may explain in large part the apparent association between schizophrenia and caffeine use.
    Arrojo-Romero M; Armas Barbazán C; López-Moriñigo JD; Ramos-Ríos R; Gurpegui M; Martínez-Ortega JM; Jurado D; Diaz FJ; de Leon J
    Schizophr Res; 2015 May; 164(1-3):234-41. PubMed ID: 25702972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.
    Malaiyandi V; Sellers EM; Tyndale RF
    Clin Pharmacol Ther; 2005 Mar; 77(3):145-58. PubMed ID: 15735609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
    Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
    Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.
    George TP; Ziedonis DM; Feingold A; Pepper WT; Satterburg CA; Winkel J; Rounsaville BJ; Kosten TR
    Am J Psychiatry; 2000 Nov; 157(11):1835-42. PubMed ID: 11058482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2A6 gene polymorphism and personality traits for NEO-FFI on the smoking behavior of youths.
    Waga C; Iwahashi K
    Drug Chem Toxicol; 2007; 30(4):343-9. PubMed ID: 17934923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of smokers with a psychotic disorder and implications for smoking interventions.
    Baker A; Richmond R; Haile M; Lewin TJ; Carr VJ; Taylor RL; Constable PM; Jansons S; Wilhelm K; Moeller-Saxone K
    Psychiatry Res; 2007 Mar; 150(2):141-52. PubMed ID: 17289155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent Dopamine D2 Antagonists Block the Reward-Enhancing Effects of Nicotine in Smokers With Schizophrenia.
    Whitton AE; Green AI; Pizzagalli DA; Roth RM; Williams JM; Brunette MF
    Schizophr Bull; 2019 Oct; 45(6):1300-1308. PubMed ID: 30690638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking and schizophrenia.
    Sagud M; Mihaljević-Peles A; Mück-Seler D; Pivac N; Vuksan-Cusa B; Brataljenović T; Jakovljević M
    Psychiatr Danub; 2009 Sep; 21(3):371-5. PubMed ID: 19794359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between tobacco smoking and positive and negative symptoms in schizophrenia.
    Patkar AA; Gopalakrishnan R; Lundy A; Leone FT; Certa KM; Weinstein SP
    J Nerv Ment Dis; 2002 Sep; 190(9):604-10. PubMed ID: 12357094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity of schizophrenia and cancer: clinical recommendations for treatment.
    Damjanović A; Ivković M; Jasović-Gasić M; Paunović V
    Psychiatr Danub; 2006 Jun; 18(1-2):55-60. PubMed ID: 16804500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia.
    Hamera E; Schneider JK; Deviney S
    J Nerv Ment Dis; 1995 Sep; 183(9):559-65. PubMed ID: 7561817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of caffeine intake and smoking on neurocognition in schizophrenia.
    Núñez C; Stephan-Otto C; Cuevas-Esteban J; Maria Haro J; Huerta-Ramos E; Ochoa S; Usall J; Brébion G
    Psychiatry Res; 2015 Dec; 230(3):924-31. PubMed ID: 26614014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of the Fagerström Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia.
    Weinberger AH; Reutenauer EL; Allen TM; Termine A; Vessicchio JC; Sacco KA; Easton CJ; McKee SA; George TP
    Drug Alcohol Depend; 2007 Jan; 86(2-3):278-82. PubMed ID: 16876968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher serum caffeine in smokers with schizophrenia compared to smoking controls.
    Gandhi KK; Williams JM; Menza M; Galazyn M; Benowitz NL
    Drug Alcohol Depend; 2010 Jul; 110(1-2):151-5. PubMed ID: 20227198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple risk factors for the initiation of smoking: the public health imperative for multidisciplinary genetic epidemiological investigations of nicotine addiction.
    Swan GE
    Nicotine Tob Res; 1999; 1 Suppl 2():S71-3; discussion S69-70. PubMed ID: 11768190
    [No Abstract]   [Full Text] [Related]  

  • 19. CYP2A6 Effects on Subjective Reactions to Initial Smoking Attempt.
    Cannon DS; Mermelstein RJ; Medina TR; Pugach O; Hedeker D; Weiss RB
    Nicotine Tob Res; 2016 May; 18(5):637-41. PubMed ID: 26541911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine intake in outpatients with schizophrenia.
    Gurpegui M; Aguilar MC; Martínez-Ortega JM; Diaz FJ; de Leon J
    Schizophr Bull; 2004; 30(4):935-45. PubMed ID: 15954199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.